Literature DB >> 1866148

Biofilm and scleral buckle-associated infections. A mechanism for persistence.

S P Holland1, J S Pulido, D Miller, B Ellis, E Alfonso, M Scott, J W Costerton.   

Abstract

Scleral buckle infections tend to be persistent as well as resistant to antimicrobial treatment. Often, scleral buckle infections require removal of the buckling elements for resolution. To determine if bacteria are able to persist on scleral buckles by elaborating a glycocalyx matrix or biofilm that offers protection against host defenses and antimicrobial treatment, the authors cultured 28 scleral buckle elements removed for infection and extrusion. Bacteria were isolated from 18 elements (64%). The most frequently isolated bacteria were Staphylococcus epidermidis and other coagulase-negative staphylococci (8), Staphylococcus aureus (3), corynebacteria (3), Mycobacterium chelonei (3), and Proteus mirabilis (3). Eleven (65%) of 17 buckles evaluated with scanning electron microscopy demonstrated the presence of bacteria encased in biofilm. Biofilm was demonstrated on the surfaces and ends of solid silicon elements. In the silicon sponges, biofilm also extended into the matrix of the sponges. The authors believe that bacterial production of biofilm offers an explanation for the persistence of scleral buckle infections and their ability to withstand antimicrobial treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1866148     DOI: 10.1016/s0161-6420(91)32199-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  20 in total

1.  An infected hydrogel buckle with Corynebacterium pseudotuberculosis.

Authors:  D T L Liu; W-M Chan; D S P Fan; D S C Lam
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

2.  Cellular fibronectin and tenascin in an orbital nylon prosthesis removed because of infection caused by Staphylococcus aureus.

Authors:  T Päällysaho; K Tervo; T Kivelä; I Virtanen; A Tarkkanen; T Tervo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-02       Impact factor: 3.117

3.  Prophylaxis for acute scleral buckle infection using 0.25 % povidone-iodine ocular surface irrigation during surgery.

Authors:  Hiroyuki Shimada; Hiroyuki Nakashizuka; Takayuki Hattori; Kyuen Otani; Ayumu Manabe; Yorihisa Kitagawa; Mitsuko Yuzawa
Journal:  Int Ophthalmol       Date:  2013-06-27       Impact factor: 2.031

4.  Production of extracellular slime by coryneforms colonizing hydrocephalus shunts.

Authors:  R Bayston; C Compton; K Richards
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

Review 5.  Biofilm Management in Wound Care.

Authors:  Chandan K Sen; Sashwati Roy; Shomita S Mathew-Steiner; Gayle M Gordillo
Journal:  Plast Reconstr Surg       Date:  2021-08-01       Impact factor: 5.169

6.  An intractable case of Pseudomonas aeruginosa infection after scleral buckling for rhegmatogenous retinal detachment.

Authors:  Nami Nishikiori; Hiroshi Ohguro
Journal:  Clin Ophthalmol       Date:  2008-03

7.  Treatment of exposed explants with donor sclera and amniotic membrane.

Authors:  Syed Khurshid Gibran; Nihal Kenawy; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-12       Impact factor: 3.535

8.  Orbital cellulitis following silicone-sponge scleral buckles.

Authors:  Arie Y Nemet; Joseph R Ferencz; Ori Segal; Amit Meshi
Journal:  Clin Ophthalmol       Date:  2013-10-31

9.  Scleral buckle infections: microbiological spectrum and antimicrobial susceptibility.

Authors:  Jay Chhablani; Sameera Nayak; Animesh Jindal; Swapna R Motukupally; Annie Mathai; Subhadra Jalali; Rajiv Reddy Pappuru; Savitri Sharma; Taraprasad Das; Harry W Flynn; Avinash Pathengay
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-12-13

10.  Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing.

Authors:  Scot E Dowd; Yan Sun; Patrick R Secor; Daniel D Rhoads; Benjamin M Wolcott; Garth A James; Randall D Wolcott
Journal:  BMC Microbiol       Date:  2008-03-06       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.